Top Markets
Coin of the day
Chengdu Easton Biopharmaceuticals Co., Ltd. Chengdu Easton Biopharmaceuticals Co., Ltd.

Chengdu Easton Biopharmaceuticals Co., Ltd.

688513
Classement en actions #9010
Chengdu Easton Biopharmaceuticals Co., Ltd. is a pharmaceutical enterprise... Chengdu Easton Biopharmaceuticals Co., Ltd. is a pharmaceutical enterprise dedicated to the full spectrum of drug development, encompassing research, development, production, and market distribution of medicinal products. The company offers finished medications tailored for various medical disciplines, including pain management (anesthetics/analgesics), cardiovascular health, oncology, and pediatrics. Beyond ready-to-use drugs, it also manufactures active pharmaceutical ingredients (APIs) for a broader range of therapeutic areas, such as cancer treatment, heart conditions, pain relief, anti-inflammatory uses, gastrointestinal issues, antiemetics, neurological and psychiatric disorders, and urinary system ailments. Established in 2009, the firm is headquartered in Chengdu, China.
Prix de l'action
$6.32
Dernière synchronisation: 2026-08-28
Capitalisation boursière
$1.11B
Changement (1 jour)
-1.63%
Changement (1 an)
-31.28%
Pays
CN
Échange Chengdu Easton Biopharmaceuticals Co., Ltd. (688513)

Catégorie

Historique du rendement du dividende pour Chengdu Easton Biopharmaceuticals Co., Ltd. (688513)
Le rendement du dividende (TTM) de Chengdu Easton Biopharmaceuticals Co., Ltd. (symbole boursier : 688513) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Chengdu Easton Biopharmaceuticals Co., Ltd. (688513) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
Entreprise Rendement du dividende Pays
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH